Cervical cancer is one of the main causes of death for middle-aged women in the developing world, till now it is completely preventable if precancerous lesions are diagnosed and treated in a timely manner.Different methods are found to control and prevent cervical cancer which involves conventional cytology (Pap smear), liquid-based cytology, human papillomavirus (HPV) screening, and vaccination against HPV Infection with HPV is the most important causal risk factor for cervical cancer, and persistence with one or more high-risk carcinogenic types is essential in the development of cervical cancer. Among women with normal cervical cytology, HPV prevalence ranges from 10-12% worldwide. Most commonly, HPV 16 and HPV 18 types are isolated from cervical cancer worldwide, but there are several oncogenic types of considerable importance, i.e. types 33, 45, 31, 58, 52, 35, 59 and51. Since DNA-based methods cannot distinguish between transient and potentially transforming infections, many studies had suggested that testing HPV E6 and E7 RNAs could be more specific. The 'gold standard' for detection of oncogenic HPV is the characterization of transcriptionally active high-risk HPV in tumo
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Cervical cancer is one of the main causes of death for middle-aged women in the developing world, till now it is completely preventable if precancerous lesions are diagnosed and treated in a timely manner.Different methods are found to control and prevent cervical cancer which involves conventional cytology (Pap smear), liquid-based cytology, human papillomavirus (HPV) screening, and vaccination against HPV Infection with HPV is the most important causal risk factor for cervical cancer, and persistence with one or more high-risk carcinogenic types is essential in the development of cervical cancer. Among women with normal cervical cytology, HPV prevalence ranges from 10-12% worldwide. Most commonly, HPV 16 and HPV 18 types are isolated from cervical cancer worldwide, but there are several oncogenic types of considerable importance, i.e. types 33, 45, 31, 58, 52, 35, 59 and51. Since DNA-based methods cannot distinguish between transient and potentially transforming infections, many studies had suggested that testing HPV E6 and E7 RNAs could be more specific. The 'gold standard' for detection of oncogenic HPV is the characterization of transcriptionally active high-risk HPV in tumo
Dr.Anfal Mohammed BSc/MSc/Phd Post graduated from college of medicine Al-Nahrain Universitylecturer at college of medicine Al- Iraqiq Universty Specialized in the field of genetics and molecular virology .
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Cervical cancer is one of the main causes of death for middle-aged women in the developing world, till now it is completely preventable if precancerous lesions are diagnosed and treated in a timely manner.Different methods are found to control and prevent cervical cancer which involves conventional cytology (Pap smear), liquid-based cytology, human papillomavirus (HPV) screening, and vaccination against HPV Infection with HPV is the most important causal risk factor for cervical cancer, and persistence with one or more high-risk carcinogenic types is essential in the development of cervical cancer. Among women with normal cervical cytology, HPV prevalence ranges from 10-12% worldwide. Most commonly, HPV 16 and HPV 18 types are isolated from cervical cancer worldwide, but there are several oncogenic types of considerable importance, i.e. types 33, 45, 31, 58, 52, 35, 59 and51. Since DNA-based methods cannot distinguish between transient and potentially transforming infections, many studies had suggested that testing HPV E6 and E7 RNAs could be more specific. The 'gold standard' for detection of oncogenic HPV is the characterization of transcriptionally active high-risk HPV in tumo 164 pp. Englisch. N° de réf. du vendeur 9786202063593
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Khudhair Anfal MohammedDr.Anfal Mohammed BSc/MSc/Phd Post graduated from college of medicine Al-Nahrain Universitylecturer at college of medicine Al- Iraqiq Universty Specialized in the field of genetics and molecular virology .C. N° de réf. du vendeur 385924054
Quantité disponible : Plus de 20 disponibles
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Cervical cancer is one of the main causes of death for middle-aged women in the developing world, till now it is completely preventable if precancerous lesions are diagnosed and treated in a timely manner.Different methods are found to control and prevent cervical cancer which involves conventional cytology (Pap smear), liquid-based cytology, human papillomavirus (HPV) screening, and vaccination against HPV Infection with HPV is the most important causal risk factor for cervical cancer, and persistence with one or more high-risk carcinogenic types is essential in the development of cervical cancer. Among women with normal cervical cytology, HPV prevalence ranges from 10-12% worldwide. Most commonly, HPV 16 and HPV 18 types are isolated from cervical cancer worldwide, but there are several oncogenic types of considerable importance, i.e. types 33, 45, 31, 58, 52, 35, 59 and51. Since DNA-based methods cannot distinguish between transient and potentially transforming infections, many studies had suggested that testing HPV E6 and E7 RNAs could be more specific. The 'gold standard' for detection of oncogenic HPV is the characterization of transcriptionally active high-risk HPV in tumoVDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 164 pp. Englisch. N° de réf. du vendeur 9786202063593
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Molecular Study of High- risk Human Papilloma Virus in Cervical Cancer | Anfal Mohammed Khudhair (u. a.) | Taschenbuch | 164 S. | Englisch | 2017 | LAP LAMBERT Academic Publishing | EAN 9786202063593 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 110555361
Quantité disponible : 5 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 164 pages. 8.66x5.91x0.37 inches. In Stock. N° de réf. du vendeur zk6202063599
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Cervical cancer is one of the main causes of death for middle-aged women in the developing world, till now it is completely preventable if precancerous lesions are diagnosed and treated in a timely manner.Different methods are found to control and prevent cervical cancer which involves conventional cytology (Pap smear), liquid-based cytology, human papillomavirus (HPV) screening, and vaccination against HPV Infection with HPV is the most important causal risk factor for cervical cancer, and persistence with one or more high-risk carcinogenic types is essential in the development of cervical cancer. Among women with normal cervical cytology, HPV prevalence ranges from 10-12% worldwide. Most commonly, HPV 16 and HPV 18 types are isolated from cervical cancer worldwide, but there are several oncogenic types of considerable importance, i.e. types 33, 45, 31, 58, 52, 35, 59 and51. Since DNA-based methods cannot distinguish between transient and potentially transforming infections, many studies had suggested that testing HPV E6 and E7 RNAs could be more specific. The 'gold standard' for detection of oncogenic HPV is the characterization of transcriptionally active high-risk HPV in tumo. N° de réf. du vendeur 9786202063593
Quantité disponible : 1 disponible(s)